Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model.
Garaiman A, Steigmiller K, Gebhard C, Mihai C, Dobrota R, Bruni C, Matucci-Cerinic M, Henes J, de Vries-Bouwstra J, Smith V, Doria A, Allanore Y, Dagna L, Anić B, Montecucco C, Kowal-Bielecka O, Martin M, Tanaka Y, Hoffmann-Vold AM, Held U, Distler O, Becker MO; EUSTAR Collaborators. Garaiman A, et al. Rheumatology (Oxford). 2023 Feb 6;62(SI):SI91-SI100. doi: 10.1093/rheumatology/keac405. Rheumatology (Oxford). 2023. PMID: 35904554
Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis.
Zampatti N, Garaiman A, Jordan S, Dobrota R, Becker MO, Maurer B, Distler O, Mihai C. Zampatti N, et al. Among authors: garaiman a. Arthritis Res Ther. 2021 Apr 22;23(1):125. doi: 10.1186/s13075-021-02506-x. Arthritis Res Ther. 2021. PMID: 33888149 Free PMC article.
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire.
Becker MO, Dobrota R, Garaiman A, Debelak R, Fligelstone K, Tyrrell Kennedy A, Roennow A, Allanore Y, Carreira PE, Czirják L, Denton CP, Hesselstrand R, Sandqvist G, Kowal-Bielecka O, Bruni C, Matucci-Cerinic M, Mihai C, Gheorghiu AM, Mueller-Ladner U, Sexton J, Kvien TK, Heiberg T, Distler O. Becker MO, et al. Among authors: garaiman a. Ann Rheum Dis. 2022 Apr;81(4):507-515. doi: 10.1136/annrheumdis-2021-220702. Epub 2021 Nov 25. Ann Rheum Dis. 2022. PMID: 34824049
The incremental value of the contribution of a biostatistician to the reporting quality in health research-A retrospective, single center, observational cohort study.
Held U, Steigmiller K, Hediger M, Cammann VL, Garaiman A, Halvachizadeh S, Losdat S, West EA, Gosteli M, Reeve KA, von Felten S, Furrer E. Held U, et al. Among authors: garaiman a. PLoS One. 2022 Mar 4;17(3):e0264819. doi: 10.1371/journal.pone.0264819. eCollection 2022. PLoS One. 2022. PMID: 35245326 Free PMC article.
Cellular determinants involving mitochondrial dysfunction, oxidative stress and apoptosis correlate with the synergic cytotoxicity of epigallocatechin-3-gallate and menadione in human leukemia Jurkat T cells.
Tofolean IT, Ganea C, Ionescu D, Filippi A, Garaiman A, Goicea A, Gaman MA, Dimancea A, Baran I. Tofolean IT, et al. Among authors: garaiman a. Pharmacol Res. 2016 Jan;103:300-17. doi: 10.1016/j.phrs.2015.12.013. Epub 2015 Dec 11. Pharmacol Res. 2016. PMID: 26687095
Detailed analysis of apoptosis and delayed luminescence of human leukemia Jurkat T cells after proton irradiation and treatments with oxidant agents and flavonoids.
Baran I, Ganea C, Privitera S, Scordino A, Barresi V, Musumeci F, Mocanu MM, Condorelli DF, Ursu I, Grasso R, Gulino M, Garaiman A, Musso N, Cirrone GA, Cuttone G. Baran I, et al. Among authors: garaiman a. Oxid Med Cell Longev. 2012;2012:498914. doi: 10.1155/2012/498914. Epub 2012 Jul 3. Oxid Med Cell Longev. 2012. PMID: 22829956 Free PMC article.
16 results